↓ Skip to main content

SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation

Overview of attention for article published in Frontiers in immunology, April 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
49 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
Published in
Frontiers in immunology, April 2022
DOI 10.3389/fimmu.2022.871276
Pubmed ID
Authors

Madison MacDougall, Jad El-Hajj Sleiman, Philippe Beauchemin, Manu Rangachari

X Demographics

X Demographics

The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 13%
Student > Master 6 11%
Other 5 9%
Student > Doctoral Student 5 9%
Researcher 5 9%
Other 5 9%
Unknown 23 41%
Readers by discipline Count As %
Medicine and Dentistry 10 18%
Neuroscience 8 14%
Biochemistry, Genetics and Molecular Biology 4 7%
Engineering 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 5 9%
Unknown 24 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2023.
All research outputs
#1,402,053
of 26,169,168 outputs
Outputs from Frontiers in immunology
#1,236
of 33,003 outputs
Outputs of similar age
#32,710
of 451,146 outputs
Outputs of similar age from Frontiers in immunology
#50
of 1,695 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,146 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 1,695 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.